Middle East & Africa CIN & HR-HPV Treatment Market Forecast to 2028 -Regional Analysis

The Middle East & Africa CIN & HR-HPV treatment market is expected to grow from US$ 534.50 million in 2023 to US$ 742.37 million by 2028. It is estimated to grow at a CAGR of 6.8% from 2023 to 2028.

Development and Launch of Innovative Products is Fueling Middle East & Africa CIN & HR-HPV Treatment Market

Companies in the healthcare market are undertaking various research and development activities to introduce advanced tests for HPV diagnosis. In May 2021, BD, a leading medical technology company, launched the first CE-marked assay for HPV screening from at-home self-collected vaginal samples. This allows laboratories to process self-collected samples through a BD diluent tube using BD Onclarity HPV assay. The at-home collection of samples helps address the urgent public health challenge of reaching out to women who do not attend routine cervical cancer screening.

Middle East & Africa CIN & HR-HPV Treatment Market Overview

The CIN & HR-HPVA market in the Middle East & Africa is segmented into the UAE, Saudi Arabia, and South Africa, and the Rest of Middle East & Africa. Saudi Arabia held the largest share of this market in 2021. Further, the market in this region is anticipated to grow at a CAGR of 3.3% during the forecast period. The projected growth in Saudi Arabia is attributed to the low incidence of HPV infection, ranking 12 among all cancers in females, accounting for only 2.4% of all new cases, despite the lack of national screening programs. Also, wide-scale vaccination programs assist in controlling HPV and related infections in the Kingdom, thereby boosting the demand for products and services required for the diagnosis and treatment of this disease.

Middle East & Africa CIN & HR-HPV Treatment Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa CIN & HR-HPV Treatment Market Segmentation

The Middle East & Africa CIN & HR-HPV treatment market is segmented into disease type, strain type, offering, product type, end user, and country. Based on disease type, the market is subsegmented into cervical intraepithelial neoplasia 1 (CIN 1), cervical intraepithelial neoplasia 2 (CIN 2), and cervical intraepithelial neoplasia 3 (CIN 3). The cervical intraepithelial neoplasia 3 (CIN 3) segment registered the largest market share in 2023.
Based on strain type, the market is segmented into HPV 16, HPV 18, and others. The HPV 16 segment held the larger market share in 2023.
Based on offering, the Middle East & Africa CIN & HR-HPV treatment market is bifurcated into diagnostic methods and treatments. The treatments segment held the largest market share in 2023. Further, diagnostic methods are segmented into pap smear, HPV testing, colposcopy, and biopsy. Further, treatments are bifurcated into excision surgery and ablation techniques.
Based on product type, the market is segmented into kits & reagents, instruments, and services. The services segment held the largest market share in 2023.
Based on end user, the market is segmented into hospitals & clinics, diagnostic laboratories, specialized clinical laboratories, and others. The hospitals & clinics segment held the largest market share in 2023.
Based on country, the Middle East & Africa CIN & HR-HPV treatment market is segmented into South Africa, Saudi Arabia, the UAE, the Rest of Middle East & Africa. South Africa dominated the market share in 2023.
Fujirebio Europe NV; Qiagen NV; Abbott Laboratories; F. Hoffmann-LA Roche Ltd; and Thermo Fisher Scientific Inc are the leading companies operating in the Middle East & Africa CIN & HR-HPV treatment market in the region.

1. Introduction

1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa CIN & HR-HPV Market - by Disease Type
1.3.2 Middle East & Africa CIN & HR-HPV Market - by Strain Type
1.3.3 Middle East & Africa CIN & HR-HPV Market - by Offering
1.3.4 Middle East & Africa CIN & HR-HPV Market - by Product Type
1.3.5 Middle East & Africa CIN & HR-HPV Market - by End User
1.3.6 Middle East & Africa CIN & HR-HPV Market - by Country

2. CIN & HR-HPV Treatment Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa CIN & HR-HPV Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion

5. Middle East & Africa CIN & HR-HPV Treatment Market - Key Market Dynamics

5.1 Market Drivers
5.1.1 Increase in Prevalence of Human Papillomavirus Infections
5.1.2 Favorable Initiatives for Preventing Cervical Cancer
5.2 Market Restraints
5.2.1 Increased Reoccurrence Rate and High Cost of CIN & HR-HPV Treatment
5.3 Market Opportunities
5.3.1 Development and Launch of Innovative Products
5.4 Future Trends
5.4.1 Use of Modern Technologies in CIN & HR-HPV Screening and Diagnosis
5.5 Impact Analysis

6. CIN & HR-HPV Market - Middle East & Africa Analysis

6.1 Middle East & Africa CIN & HR-HPV Market Revenue Forecast and Analysis

7. Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts To 2028- by Disease Type

7.1 Overview
7.2 Middle East & Africa CIN and HR-HPV Treatment Market, By disease type, 2022 & 2028 (%)
7.3 CIN 1
7.3.1 Overview
7.3.2 CIN 1: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
7.4 CIN 2
7.4.1 Overview
7.4.2 CIN 2: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
7.5 CIN 3
7.5.1 Overview
7.5.2 CIN 3: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8. Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts To 2028- by Strain Type

8.1 Overview
8.2 HPV 16
8.2.1 Overview
8.2.2 HPV 16: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.3 HPV 18
8.3.1 Overview
8.3.2 HPV 18: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9. Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts To 2028- by Offering

9.1 Overview
9.2 Middle East & Africa CIN and HR-HPV Treatment Market, By Offering, 2022 & 2028 (%)
9.4 Diagnostic Method
9.4.1 Overview
9.4.2 Diagnostic Method: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.4.3 Pap Smear
9.4.3.1 Overview
9.4.3.2 Pap Smear: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.4.4 HPV Testing
9.4.4.1 Overview
9.4.4.2 HPV Testing: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5 Colposcopy
9.4.5.1 Overview
9.4.5.2 Colposcopy: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.4.6 Biopsy
9.4.6.1 Overview
9.4.6.2 Biopsy: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Treatment
9.5.1 Overview
9.5.2 Treatment: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.5.2.1 Excision Surgery
9.5.2.1.1 Overview
9.5.2.1.2 Excision Surgery: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
9.5.2.2 Ablation Techniques
9.5.2.2.1 Overview
9.5.2.2.2 Ablation Techniques: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10. Middle East & Africa CIN & HR-HPV Treatment Market Analysis and Forecast to 2028 - by Product Type

10.1 Overview
10.2 Middle East & Africa CIN & HR-HPV Treatment Market, by Product Type 2022 & 2028 (%)
10.3 Kits & Reagents
10.3.1 Overview
10.3.2 Kits & Reagents: CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Instrument
10.4.1 Overview
10.4.2 Instrument: CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Services
10.5.1 Overview
10.5.2 Services: CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)

11. Middle East & Africa CIN & HR-HPV Treatment Market Analysis and Forecast to 2028 - by End User

11.1 Overview
11.2 Middle East & Africa CIN & HR-HPV Treatment Market, by End User 2022 & 2028 (%)
11.3 Hospital & Clinics
11.3.1 Overview
11.3.2 Hospital & Clinics: CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.4 Diagnostic Laboratories
11.4.1 Overview
11.4.2 Diagnostic Laboratories: CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.5 Specialized Clinical Laboratories
11.5.1 Overview
11.5.2 Specialized Clinical Laboratories: CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.6 Others
11.6.1 Overview
11.6.2 Others: CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)

12. Middle East & Africa CIN & HR-HPV Treatment Market Revenue and Forecasts to 2028 - Country Analysis

12.1 Middle East & Africa CIN & HR-HPV Market
12.1.1 Overview
12.1.1.1 UAE: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.1 Overview
12.1.1.1.2 UAE: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.3 UAE: CIN & HR-HPV Market, by Disease Type, 2019-2028 (US$ Million)
12.1.1.1.4 UAE: CIN & HR-HPV Market, by Strain Type, 2019-2028 (US$ Million)
12.1.1.1.5 UAE: CIN & HR-HPV Market, by Offering, 2019-2028 (US$ Million)
12.1.1.1.5.1 UAE: CIN & HR-HPV Market, by Diagnostic Method, 2019-2028 (US$ Million)
12.1.1.1.5.2 UAE: CIN & HR-HPV Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.1.6 UAE: CIN & HR-HPV Market, by Product Type, 2019-2028 (US$ Million)
12.1.1.1.7 UAE CIN & HR-HPV Market, by End User, 2019-2028 (US$ Million)
12.1.1.2 Saudi Arabia: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.1 Overview
12.1.1.2.2 Saudi Arabia: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.3 Saudi Arabia: CIN & HR-HPV Market, by Disease Type, 2019-2028 (US$ Million)
12.1.1.2.4 Saudi Arabia: CIN & HR-HPV Market, by Strain Type, 2019-2028 (US$ Million)
12.1.1.2.5 Saudi Arabia: CIN & HR-HPV Market, by Offerings, 2019-2028 (US$ Million)
12.1.1.2.5.1 Saudi Arabia: CIN & HR-HPV Market, by Diagnostic Methods, 2019-2028 (US$ Million)
12.1.1.2.5.2 Saudi Arabia: CIN & HR-HPV Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.2.6 Saudi Arabia: CIN & HR-HPV Market, by Product Type, 2019-2028 (US$ Million)
12.1.1.2.7 Saudi Arabia CIN & HR-HPV Market, by End User, 2019-2028 (US$ Million)
12.1.1.3 South Africa: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.1 Overview
12.1.1.3.2 South Africa: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.3 South Africa: CIN & HR-HPV Market, by Disease Type, 2019-2028 (US$ Million)
12.1.1.3.4 South Africa: CIN & HR-HPV Market, by Strain Type, 2019-2028 (US$ Million)
12.1.1.3.5 South Africa: CIN & HR-HPV Market, by Offering, 2019-2028 (US$ Million)
12.1.1.3.5.1 South Africa: CIN & HR-HPV Market, by Diagnostic Method, 2019-2028 (US$ Million)
12.1.1.3.5.2 South Africa: CIN & HR-HPV Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.3.6 South Africa: CIN & HR-HPV Market, by Product Type, 2019-2028 (US$ Million)
12.1.1.3.7 South Africa CIN & HR-HPV Market, by End User, 2019-2028 (US$ Million)
12.1.1.4 Rest of Middle East & Africa: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.4.1 Overview
12.1.1.4.2 Rest of Middle East & Africa: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.4.3 Rest of Middle East & Africa: CIN & HR-HPV Market, by Disease Type, 2019-2028 (US$ Million)
12.1.1.4.4 Rest of Middle East & Africa: CIN & HR-HPV Market, by Strain Type, 2019-2028 (US$ Million)
12.1.1.4.5 Rest of Middle East & Africa: CIN & HR-HPV Market, by Offering, 2019-2028 (US$ Million)
12.1.1.4.5.1 Rest of Middle East & Africa: CIN & HR-HPV Market, by Diagnostic Method 2019-2028 (US$ Million)
12.1.1.4.5.2 Rest of Middle East & Africa: CIN & HR-HPV Market, by Treatment, 2019-2028 (US$ Million)
12.1.1.4.6 Rest of Middle East & Africa: CIN & HR-HPV Market, by Product Type, 2019-2028 (US$ Million)
12.1.1.4.7 Rest of Middle East & Africa CIN & HR-HPV Market, by End User, 2019-2028 (US$ Million)

13. Middle East & Africa CIN & HR-HPV Treatment Market - Industry Landscape

13.1 Overview
13.2 Growth Strategies in CIN & HR-HPV Treatment Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview

14. Company Profiles

14.1 Fujirebio Europe NV
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 .Key Developments
14.2 Qiagen NV
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott Laboratories
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 F. Hoffmann-La Roche Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Thermo Fisher Scientific Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

15. Appendix

15.1 About The Publisher
15.2 Glossary of Terms

List of Tables

Table 1. UAE CIN & HR-HPV Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE CIN & HR-HPV Market, by Strain Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. UAE CIN & HR-HPV Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE CIN & HR-HPV Market, by Diagnostic Method - Revenue and Forecast to 2028 (US$ Million)
Table 5. UAE CIN & HR-HPV Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 6. UAE CIN & HR-HPV Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 7. UAE CIN & HR-HPV Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Saudi Arabia CIN & HR-HPV Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Saudi Arabia CIN & HR-HPV Market, by Strain Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. Saudi Arabia CIN & HR-HPV Market, by Offerings - Revenue and Forecast to 2028 (US$ Million)
Table 11. Saudi Arabia CIN & HR-HPV Market, by Diagnostic Methods - Revenue and Forecast to 2028 (US$ Million)
Table 12. Saudi Arabia CIN & HR-HPV Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 13. Saudi Arabia CIN & HR-HPV Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Saudi Arabia CIN & HR-HPV Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. South Africa CIN & HR-HPV Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 16. South Africa CIN & HR-HPV Market, by Strain Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. South Africa CIN & HR-HPV Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 18. South Africa CIN & HR-HPV Market, by Diagnostic Method - Revenue and Forecast to 2028 (US$ Million)
Table 19. South Africa CIN & HR-HPV Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 20. South Africa CIN & HR-HPV Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 21. South Africa CIN & HR-HPV Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Middle East & Africa CIN & HR-HPV Market, by Disease Type - Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Middle East & Africa CIN & HR-HPV Market, by Strain Type - Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Middle East & Africa CIN & HR-HPV Market, by Offering - Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Middle East & Africa CIN & HR-HPV Market, by Diagnostic Method - Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Middle East & Africa CIN & HR-HPV Market, by Treatment - Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Middle East & Africa CIN & HR-HPV Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Middle East & Africa CIN & HR-HPV Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 29. Recent Organic Growth Strategies in CIN & HR-HPV Treatment Market
Table 30. Recent Inorganic Growth Strategies in the CIN & HR-HPV Treatment Market
Table 31. Glossary of Terms

List of Figure

Figure 1. Middle East & Africa CIN & HR-HPV Market Segmentation
Figure 2. Middle East & Africa CIN & HR-HPV Market, by Country
Figure 3. Middle East & Africa CIN & HR-HPV Market Overview
Figure 4. Cervical Intraepithelial Neoplasia 3 Segment Held Largest Share of Disease Type Segment in CIN & HR-HPV Market
Figure 5. South Africa Expected to Show Remarkable Growth During Forecast Period
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Middle East & Africa Experts’ Opinion
Figure 8. Middle East & Africa CIN & HR-HPV Market: Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa CIN & HR-HPV Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. Middle East & Africa CIN and HR-HPV Treatment Market, by disease type, 2022 & 2028 (%)
Figure 11. CIN 1: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. CIN 2: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. CIN 3: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Middle East & Africa CIN and HR-HPV Treatment Market, by Strain Type, 2022 & 2028 (%)
Figure 15. HPV 16: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. HPV 18: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Others: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Middle East & Africa CIN and HR-HPV Treatment Market, by offering, 2022 & 2028 (%)
Figure 19. Diagnostic Method: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Pap Smear: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. HPV Testing: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Colposcopy: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Biopsy: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Treatment: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Excision Surgery: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Ablation Techniques: Middle East & Africa CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Middle East & Africa CIN & HR-HPV Treatment Market, by Product Type 2022 & 2028 (%)
Figure 28. Kits & Reagents: Middle East & Africa CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Instrument: Middle East & Africa CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Services: Middle East & Africa CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Middle East & Africa CIN & HR-HPV Treatment Market, by End User 2022 & 2028 (%)
Figure 32. Hospital & Clinics: Middle East & Africa CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Diagnostic Laboratories: Middle East & Africa CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Specialized Clinical Laboratories: Middle East & Africa CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Others: Middle East & Africa CIN & HR-HPV Treatment Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Middle East & Africa: CIN & HR-HPV Market, by Key Country - Revenue (2022) (US$ Million)
Figure 37. Middle East & Africa: CIN & HR-HPV Market, by Country, 2022 & 2028 (%)
Figure 38. UAE: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Saudi Arabia: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. South Africa: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Rest of Middle East & Africa: CIN & HR-HPV Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Growth Strategies in CIN & HR-HPV Treatment Market

Companies Mentioned

Fujirebio Europe NV
Qiagen NV
Abbott Laboratories
F. Hoffmann-LA Roche Ltd
Thermo Fisher Scientific Inc

Table Information

Report Attribute	Details
No. of Pages	101
Published	June 2023
Forecast Period	2023 - 2028
Estimated Market Value ( USD ) in 2023	$ 534.5 million
Forecasted Market Value ( USD ) by 2028	$ 742.37 million
Compound Annual Growth Rate	6.8%
Regions Covered	Africa, Middle East
No. of Companies Mentioned	5

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2075EUR$2,100USD£1,727GBP €2964EUR$3,000USD£2,467GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2767EUR$2,800USD£2,303GBP €3952EUR$4,000USD£3,290GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3458EUR$3,500USD£2,878GBP €4940EUR$5,000USD£4,112GBP

Development and Launch of Innovative Products is Fueling Middle East & Africa CIN & HR-HPV Treatment Market

Middle East & Africa CIN & HR-HPV Treatment Market Overview

Middle East & Africa CIN & HR-HPV Treatment Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa CIN & HR-HPV Treatment Market Segmentation

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

HPV Associated Disorders Market by Indication, Therapy, Distribution - Global Forecast 2025-2030

High Risk Hpv Infections - Market Insight, Epidemiology and Market Forecast - 2034

Human Papillomavirus (HPV) Associated Disorders - Market Insight, Epidemiology and Market Forecast - 2034

Sexually Transmitted Diseases (STDs) Drug - Global Strategic Business Report

Immunopathology, Diagnosis and Treatment of HPV induced Malignancies. Developments in Microbiology